Global Bariatric Surgery Devices Market Set To Grow To $1.5bn By 2023

02 August 2018
Pharma

Visiongain’ has launched a new pharma report Global Bariatric Surgery Devices Market Forecast 2018-2028: Assisting Devices, Implantable Devices, Suturing Devices, Stapling Devices, Closure Devices, Trocars, Gastric Bands, Intragastric Balloons, Single Intragastric Balloons, Dual Intragastric Balloons, Triple Intragastric Balloons, Electrical Stimulation Devices, Gastric Emptying, Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, Bariatric Surgery Clinics, Ambulatory Surgical Centres, Hospital Pharmacies

The bariatric surgery devices market is expected to witness a significant growth over the forecast period. The main drivers for the growth include rapid growth in the number of obese patients, growing incidences of obesity-related chronic disorders, and technological innovations in bariatric surgery systems. Additionally, government initiatives to curb obesity and related problems along with insurance coverage for bariatric procedures will further contribute to the growth of the market.

The lead analyst of the report commented “The demand for minimal invasive surgeries is growing rapidly as they save time, cost, and reduced hospital stay. In addition to this, governments are also encouraging the adoption of minimal invasive surgeries to lower the incidences of infection. Key players are striving to change the traditional methods of surgeries and developing innovative techniques to enable surgeons to perform bariatric surgeries more effectively.”

Leading companies featured in the report include Johnson & Johnson, Aspire Bariatrics, Inc.
GI Dynamics, Inc., Intuitive Surgical, Inc., Medtronic plc, Apollo Endosurgery, Inc., Mediflex, Cousin Biotech, Spatz FGIA Inc., The DACH Medical Group Holding AG (DACH), EnteroMedics Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Ophthalmic Drugs market set to grow to $33bn by 2024” says new Visiongain report

The market for ophthalmic drugs is a growing one.

17 June 2019

Read

“Generic Drugs market set to grow to $424bn by 2024” says new Visiongain report

Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.

14 June 2019

Read

“Global Precision Cancer Diagnostic Tests market set to grow to $21.3bn by 2024” says new Visiongain report

The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.

06 June 2019

Read

“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

04 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever